Clinical study of nimotuzumab combined with concurrent radiochemotherapy for treatment of locally advanced cervical cancer

PURPOSE: Nimotuzumab is a humanized monoclonal antibody that targets the epidermal growth factor receptor (EGFR) to inhibit tumor growth. Nimotuzumab has demonstrated desirable therapeutic activity in various types of tumors. However, the benefit of nimotuzumab for the treatment of cervical cancer i...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Wenli, Li, Tao, Wang, Jian, Liang, Long, Huang, Dandan, Yan, Gaoshu, Tian, Ye, Zhang, Xiaoli, Zhang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731987/
https://www.ncbi.nlm.nih.gov/pubmed/31564975
http://dx.doi.org/10.2147/CMAR.S191134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731987/
https://www.ncbi.nlm.nih.gov/pubmed/31564975
http://dx.doi.org/10.2147/CMAR.S191134

Ejemplares similares